ResearcherUniversity of California, San FranciscoActive in the last 2 years

Ronald J. Parchem

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0038-2806; OpenAlex author ID A5045796079. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 grant

Papers 1

Oncogenic KRAS promotes pancreatic ductal adenocarcinoma (PDAC) through post-transcriptionally regulated KRAS-induced granules (KGs) Last author DOI 10.21203/rs.3.rs-3064215/v1 ↗

Grants 1

Innovation & Collaboration grant: Ronald Parchem (mechanisms driving tumor innervation) AWARD lustgarten:2025-ronald-parchem-phd-innovation-collaboration-grant-ronald-pa

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Angelina S. Bortoletto · 1 shared paper, 2023 · strength 0.22
- Paper Oncogenic KRAS promotes pancreatic ductal adenocarcinoma (PDAC) through post-transcriptionally regulated KRAS-induced g… DOI 10.21203/rs.3.rs-3064215/v1 ↗
Frank Patrick Mccormick · 1 shared paper, 2023 · strength 0.22
- Paper Oncogenic KRAS promotes pancreatic ductal adenocarcinoma (PDAC) through post-transcriptionally regulated KRAS-induced g… DOI 10.21203/rs.3.rs-3064215/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.